Table 2.
Summary of compliance in dried blood spot collection over the 28-day study period for adults and children
| Adult females | Adult males | Children | All | |
|---|---|---|---|---|
| Excellent or Good compliers (≥ 16 samples collected)a | 60/60 (100%) | 36/39 (92%) | 27/28 (96%) | 123/127 (96%) |
| Fair or poor compliers (< 16 samples collected)a | 0/60 (0%) | 3/39 (8%) | 1/28 (4%) | 4/127 (3.1%) |
| Developed RDT(+) falciparum malaria during studyb | 1/60 (1.6%) | 2/42 (4.8%) | 2/29 (6.9%) | 5/131 (3.8%) |
| Discontinued in week 1b | 0/60 (0%) | 1/42 (2.4%) | 0/29 (0%) | 1/131 (0.8%) |
| Discontinued in week 2b | 0/60 (0%) | 0/41(0%) | 0/29 (0%) | 0/130 (0%) |
| Discontinued in week 3b | 0/60 (0%) | 1/40 (2.5%) | 1/29 (3.5%) | 2/129 (1.6%) |
| Discontinued in week 4b | 1/59 (1.7%) | 1/38 (2.6%) | 0/26 (0%) | 2/123 (1.6%) |
A total of 24 home blood spots were possible for individuals that completed the entire study
aDenominator includes DBS samples received at University of Washington laboratory and excludes 1 individual (adult male) who developed malaria before Day 18 of study
bDenominator includes all participants enrolled in study. Excludes any individuals who discontinued because of malaria in given week